Pay in 4 interest-free payments of $6.98 Learn more
Ships within 48 hours · Estimated delivery Sep 28 - Oct 3
This is harmless and does not indicate the treatment is ineffective
Individuals using GLP-1 medications may experience: Reduced caloric and protein intake Early satiety or nausea Gastrointestinal changes that affect absorption Increased fatigue during metabolic adjustment Because B-complex vitamins support energy metabolism, neurological pathways, and gastrointestinal integrity, supportive supplementation may be considered when intake is reduced or oral tolerance is limited
Safety data from trials In a paper summarizing 6 randomized, double-blind, placebo-controlled human trials, AOD 9604 did not significantly affect IGF-1 levels, did not impair glucose tolerance, and no serious adverse events (SAEs) were attributed to AOD 9604
AOD-9604 is a fat-burning peptide derived from growth hormone, designed to accelerate metabolism and support weight loss
